IMPORTANT NOTE. We strongly recommend that you consult your doctor for proper advice before using any medications, including vitamins, supplements, herbals and products for the skin.
Brand Name, Dosage Format and Strength
Kastair EZTab 5 mg TABLET
Corticosteroid, Anticholinergic, Beta2-Agonist, Leukotriene Inhibitor, Beta2-Agonist, Beta2-Agonist, Expectorant, Antiasthma-Beta2- Agonist, Mucolytic, Beta2-Agonist, Mucolytic, Antitussive, Nasal Decongestant, Analgesic-Antipyretic, Antitussive, Nasal Decongestant, Analgesic-Antipyretic, Nasal Decongestant, Antihistamine, Nasal Decongestant, Antihistamine, Analgesic-Antipyretic, Nasal Decongestant, Analgesic-Antipyretic, Alpha Adrenergic Agonist, Nasal Decongestant, Antihistamine, Analgesic-Antipyretic
STATEMENT ON USAGE FOR HIGH RISK GROUPS
Pregnancy: The safe use of the product during pregnancy has not been established. Therefore, montelukast should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus.
There have been rare reports of congenital limb defects in children of patients treated with montelukast. Most of the mothers, however, were receiving other asthma medications in the course of their pregnancies. Since there is no consistent pattern of congenital abnormality development, a relationship between the use of montelukast and the development of congenital anomalies cannot be established.
Lactation: It is not known if montelukast is excreted in human milk. Therefore, do not administer to breastfeeding women unless, in the opinion of a physician, the potential benefits of the drug justify the possible risk.
Children: The safety and efficacy of montelukast in infants younger than 6 mos old have not been established.
Elderly: There were no differences observed between the elderly and younger patients in the efficacy and safety profiles of montelukast.